Cisplatin + Gemcitabine + Bevacizumab

From OncoWiki
Revision as of 02:18, 7 February 2012 by Palmdoc (talk | contribs) (1 revision)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

Indication

Chemotherapy for stage IV (metastatic) cancer

  • Cisplatin 80 mg/m2 iv d1q3w x 6 cycles
  • Gemcitabine (Gemzar) 1250 mg/m2 iv d1, 8 q3w x 6 cycles
  • Bevacizumab (Avastin) 7.5-15 mg/kg iv q3w till disease progression

References

Manegold C et al. Randomized, double-blinded multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naive patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): B017704. 2007 ASCO annual meeting. LBA7514